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ABSTRACT
GALNT11 IS A NOVEL GALNAC-TRANSFERASE THAT GLYCOSYLATES NOTCH1
RECEPTOR TO SPECIFY BETWEEN MOTOR AND SENSORY CILIARY FATES IN
THE VERTEBRATE LEFT-RIGHT ORGANIZER.
Marko T. Boskovski, Mustafa Khokha and Martina Brueckner. Section of Cardiology,
Department of Pediatrics, Yale University, School of Medicine, New Haven, CT.

Heterotaxy is a disease of abnormal left-right (LR) body patterning associated with
congenital heart disease that has very poor outcomes. Despite advances in surgical
management, the two most severe forms of heterotaxy, right and left atrial isomerism, have a
29% and 64% 5-year survival rate, respectively. Through copy number variant analysis of
heterotaxy patients, GALNT11 was recently identified as a novel gene important in human
LR development. However, the mechanism by which Galnt11 causes heterotaxy has not been
elucidated. In order to discover the mechanism of GALNT11 in patterning the LR axis, I
performed loss of function and gain of function studies in Xenopus tropicalis and expression
analysis in Mus musculus. In Xenopus, knockdown of galnt11 = induced heart looping
defects that were successfully rescued with human GALNT11 mRNA indicating that the
phenotype was specific to Galnt11. Via immunohistochemistry, Galnt11 protein strongly
localizes to the crown cells surrounding the LRO. Manipulations of Galnt11 altered the
density of ciliated epidermal cells, but based on gliding assays and ultrastructural analysis did
not alter the cilia. Galnt11 and Notch effects on epidermal ciliated epidermal cell density,
heart looping, as well as PitX2 and Coco expression were very similar, and Galnt11
morphants were rescued with Notch ICD and Su(H)-Ank, but not Delta suggesting that

galnt11 acts in the notch pathway downstream of the ligand. GALNT11 RNA no longer had
any effect on heart looping or PitX2 expression following a conservative point mutation of its
catalytic glycosylation domain. Galnt11 morphants had significantly narrower LROs, and
much stronger expression of motile ciliary markers FoxJ1 and RFX2, while GALNT11 RNA
injected embryos had almost no detectable FoxJ1 and RFX2. Taken together, these results
indicate that Galnt11 is a GalNAc-transferase that is necessary for proper left-right axis
establishment and heart looping. Its function is to specify between motile and sensory cell
fates at the Left-Right Organizer by glycosylating Notch receptor and modifying Notch
signaling.
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I. INTRODUCTION
I.1. Heterotaxy Syndrome
The heart is the most visibly asymmetric organ in the human body. It is positioned in
the left chest, and is tilted such that the apex points in a left antero-inferior direction, thereby
placing the right ventricle most anterior and the left atrium most posterior but anterior of the
trachea. Following the blood flow, the heart has asymmetric venous drainage into the atria.
The superior and inferior vena cava drain into the right atrium, while four pulmonary veins
drain into the left atrium. The blood then goes through the asymmetrically coiled semilunar
valves – the bicuspid mitral valve on the left and the tricuspid valve on the right to enter the
ventricles, which are not only asymmetrically oriented, but also anatomically and
functionally distinct. The ventricles then pump blood through the aortic and pulmonary
valves into the asymmetrically coiled great vessels. It is obvious then, that precise
developmental asymmetry across the left-right (LR) axis is essential for proper heart
function.
Failure to properly develop LR asymmetry leads to a group of disorders that are
collectively referred to as heterotaxy syndrome. In heterotaxy, organs or asymmetric
structures within organs fail to properly align relative to each other. Given the highly
asymmetric structure of the heart itself, and the structures surrounding the heart, failure of
these processes results in a plethora of congenital heart disease.
Positioning along the LR axis can be divided into three broad categories (Fig. 1).
Situs solitus refers to the proper alignment of organs across the LR axis. Situs inversus, with
an incidence of 1 in 8500 in the general population, refers to a mirror image arrangement of
organs across the LR axis when compared to situs solitus, and is not usually associated with

2
intra-cardiac defects. Heterotaxy covers the spectrum of LR axis malformations that fall in
between situs solitus and situs inversus. It has an incidence of 1 in 10,000 in the general
population, and has a very high association with intra-cardiac defects.1

Situs
Solitus
Right
Lung

Right Atrial
Isomerism

Left Atrial
Isomerism

Situs
Inversus

Left
Lung
Heart

Liver
Stomach
Spleen

Heterotaxy Spectrum
Figure 1. A schematic representation of the spectrum of heterotaxy disorders. Situs solitus
on the left represents normal organ arrangement across the LR axis, while situs inversus on
the right is its mirror image. Any organ or intraorgan arrangement in between situs solitus
and situs inversus is considered heterotaxy, represented by right and left atrial isomerism in
the middle two panels. Reproduced with permission from Martina Brueckner.
Heterotaxy itself represents a range of disorders. In minor cases there is partial development
of asymmetry where there is discordance between organs (e.g. isolated dextrocardia with
abdominal situs solitus) or discordance within one organ (e.g. isolated levo transposition of
the great vessels with a levo-ventricular loop and normal atrial and abdominal situs). The
most severe cases result from complete failure to develop asymmetry across the LR axis in
the whole body, thus leading to Ivemark syndrome, also referred to as right and left atrial
isomerisms. In essence, in right atrial isomerism the body has two “right” sides (with
bilateral right atria), while in left atrial isomerism the body has two “left” sides (with bilateral
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left atria). The intracardiac anatomy in isomerism is highly complex, with intracardiac
defects found in 83% of left atrial isomerism and 100% of right atrial isomerism diagnosed
prenatally.2 The most prevalent defect across both left and right atrial isomerism is an
atrioventricular septal defect, affecting from 60% to 100% of patients. Complex
abnormalities of systemic and pulmonary venous drainage, along with malposition of the
great vessels and subpulmonary or aortic obstruction, coexist in the majority of cases. The
long-term outcome for patients with isomerism has remained poor despite improvements in
the medical and surgical management of other congenital heart disease: the 5-year survival
for patients with left atrial isomerism and right atrial isomerism is reported to be only 64%
and 29%, respectively.3
Given the prevalence and severity of disease in heterotaxy, an understanding of LR
patterning in vertebrate model organisms is essential. Such understanding has the potential to
not only help us delineate the pathogenesis of different heterotaxy cases, but with recent
advances in genetic sequencing, also inform us about the prognosis and treatment of these
patients.

I.2. Overview of vertebrate left-right asymmetry development
In vertebrates, the LR axis develops through a highly organized and regulated series
of events. In simple terms, this process can be divided into three broad stages. The first
involves the LRO, a transient, ciliated organ present early in development, which creates
asymmetric cilia driven flow. This event represents the initial symmetry breaking point
across the LR axis. The second stage involves asymmetric gene expression, which is induced
by the asymmetric flow. This differential gene expression is then propagated throughout
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embryo development to instruct the third and final event in embryo development: asymmetric
organogenesis.
As is the case with all of biology, this simple scaffold is overlaid with a myriad of
regulatory mechanisms, including Notch, Nodal, Hedgehog, FGF, Wnt and BMP.4-7 In the
past decade, Notch signaling has emerged as a central regulatory component at several points
during the LR developmental cascade.
This introduction will first cover in detail the three broad stages of LR development,
followed by a discussion on Notch signaling in general and more specifically as it applies to
LR development. The focus will then shift to the genetics of heterotaxy and how recent
findings from heterotaxy patients have revolutionized the field of LR development. The
introduction will conclude with a discussion on Galnt11, a novel glycosylation factor that
was identified through a copy number variant analysis of heterotaxy patients which I have
demonstrated to affect LR patterning via the Notch pathway.

I.3. The LRO is a conserved ciliated signaling center that breaks LR asymmetry
Despite the significantly different anatomy of various vertebrate species, central to
the first stage of LR development is a conserved, homologous vertebrate structure called the
Hensen’s node in chick,8 node in mouse,9 posterior notochord (PNC) in rabbit,10,11 Kuppfer’s
vesicle (KV) in fish,10 and gastrocoel roof plate (GRP) in frog,12 which we will collectively
refer to as the left-right organizer (LRO) (Fig.2). The LRO forms towards the end of
gastrulation and is composed of 50-250 monociliated cells. The synchronized rotation of the
cilia on these cells creates a leftward laminar fluid flow of the extracellular fluid above the
LRO (Fig. 3).13 Using high-speed video microscopy, in the mouse the LRO cilia have been
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observed to rotate at a speed of 600 rpm to drive a flow of ~15-20 µm/second.13 Similarly,
the LRO flow has been observed in frog by tracking fluorescent beads.12 The end result of
this leftward flow is the induction of the second stage of LR development, asymmetric gene
expression.

Figure 2. Comparison of the LRO in different vertebrate species. A-C Diagrams of
developing mouse, frog and fish embryos. The location of the LRO is outlined in red. D-F
Immunofluorescence pictures of the corresponding LRO. Monocilia are labeled with
acetylated tubulin (red) and cell nuclei are labeled with Hoechst (blue).
There are several lines of evidence supporting that the LRO is a homologous structure
that is conserved throughout vertebrate species. A ciliated LRO organizer has been identified
in every major vertebrate model system (Fig. 2), although it has been difficult to definitively
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identify the ciliated LRO in chick.14 In each case, the cilia have been documented to be
motile, and consequently, to produce leftward flow. Furthermore, it is always derived from
the superficial mesoderm and has flanking expression of homologs of the gene Nodal
(discussed below). Finally, mechanical destruction of LRO precursor cells in frog,15 or the
LRO itself in zebrafish10 yields laterality defects (i.e. situs inversus and heterotaxy) in the
face of normal AP and DV development, indicating that the LRO is not only a conserved
structure, but also one that is required for normal LR development. The ciliated LRO has not
actually been visualized in the human embryo for obvious ethical reasons; however, a
combination of the remarkable conservation of a cilia-driven flow mechanism for initiating
LR asymmetry in vertebrates, and the association between human ciliopathies (see below)
and situs abnormalities, makes it highly likely that there is an LRO in the early human
embryo also.

Figure 3. Schematic of the mouse LRO. Motile cilia on pit cells (shown with green arrows
on dark gray cells) generate leftward flow of extracellular fluid (shown as blue arrow).
Sensory cilia on crown cells (shown as red arrows on light gray cells) transduce flow
information into asymmetric signals, including increased intracellular calcium in the cells
at the left. This leads to subsequent asymmetric gene expression.
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I.4. LRO cilia are chiral organelles that induce LR asymmetry from positional cues derived
from the AP and DV axes
The LR axis is unique in that it is defined with respect to the anteroposterior (AP) and
dorsoventral (DV) axes. Therefore, the embryo must have mechanisms to both create
asymmetry and to consistently align the asymmetry with the existing AP and DV axes. This
predicts that failure to create asymmetry results in retained bilateral symmetry, manifesting
as left or right atrial isomerism. In contrast, inability to align the asymmetry manifests as
random asymmetry, such as the 50% incidence of situs inversus totalis observed in patients
with primary ciliary dyskinesia. Wilhelmi originally proposed that the organism has an
underlying mechanism that generates random asymmetry.16 Brown and Wolpert
hypothesized that this asymmetry is biased in a consistent direction by the presence of a
handed asymmetric molecule or macromolecular structure that can align with the AP and DV
axes, which they represented by the letter "F".17
Extensive work in model systems including zebrafish, Xenopus and mouse indicates
that the initial handed reference structure is the cilium, a highly chiral organelle that is found
on almost all cells. Specifically, it is the cilia positioned on the ventral surface of the LRO
that orient the LR axis relative to the established AP and DV axes. This is established
through the rotational angle of the cilia, which in separate studies have been found to be
tilted 40 ± 10° and 15–35° posteriorly in mouse.18,19 Hemodynamic principles dictate that if
cilia are uniformly tilted in a specific direction, then it is possible to create unidirectional
flow with rotational ciliary motion through a no-slip boundary effect.20 When cilia move
closer to the surface, the movement of the fluid they drive will be retarded by the viscous
forces of the stationary fluid that is in immediate contact with the surface. Conversely, when
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the same cilia move in the opposite direction away from the surface, they can freely drive the
fluid with no opposing forces due to static surfaces.21-24 The end result is unidirectional
motion in the direction of the halfstroke when the cilium is oriented away from the cell
surface. In the case of the LRO, the cilia are tilted posteriorly and they rotate in a clockwise
direction. According to the principles described above, almost no fluid flow is generated on
the rightward half-stroke when the cilia are close to the surface, and robust fluid flow is
generated on the leftward half-stroke when the cilia are away from the surface, thereby
creating the overall leftward fluid flow that is observed.
It becomes apparent then, that proper development of both the AP and DV axes are
required for correct LR patterning. The DV axis instructs the protrusion of cilia on the ventral
side of the LRO,9 while the AP axis is necessary for proper posterior tilt. The answer to how
a posterior tilt is achieved lies in the spherical shape of the LRO cells containing motile cilia.
A careful examination of these cells in both mouse and frog reveals that the basal bodies and
the cilia are located posteriorly, thereby forcing a posterior tilt of the cilium as it protrudes
outside.18,19

I.5. Structure and Function of Cilia
Essential for normal LRO function and subsequent normal LR development is the
proper function of the LRO monocilia. Cilia, in general, are large, complex organelles that,
depending on the tissue they are found in, protrude up to 20µm beyond the cytoplasm.25 They
are composed of the ciliary axoneme surrounded by the ciliary membrane, which is
contiguous with the plasma membrane. The axoneme comprises the microtubule skeleton
consisting of 9 microtubule (MT) doublets with attached intraflagellar transport (IFT)
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proteins. Since there is no protein synthesis in cilia, IFT proteins are required to selectively
transport the structural and functional components of cilia from the cytoplasm into the
axoneme, and to return products of ciliary signaling to the cytoplasm (Fig. 4).

Figure 4. Schematic representation of a cilium. The microtubule based structure is
assembled at the basal body (epithelial cilia) or the mother centriole (monocilia). Proteins
necessary for proper ciliary function go from the Golgi to the base of the cilium via IFT
proteins where they are transported up the cilium in anterograde fashion by kinesin motor
proteins, and down the cilium in retrograde fashion by the dynein motor proteins. Inset A
Electron micrograph (EM) of a monocilium lacking a central microtubule pair B EM of a
motile epithelial cilium with a central microtubule pair.
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Cilia can be subdivided into epithelial cilia and primary cilia. Epithelial cilia, such as
those found on the apical surface of epithelial cells of the trachea, choroid plexus and
oviduct, contain motor proteins, as well as a central pair of MTs linked by radial spokes to
the outer 9 doublets. The motor proteins – a combination of outer and inner arm dynein
motors – along with their associated dynein regulatory proteins, hydrolyze ATP to generate
ciliary movement. Typically there are many cilia per epithelial cell that arise from basal
bodies beneath the cell membrane, which themselves originate from the template of the
mother centriole. The concerted action of large numbers of closely spaced motile cilia
transports surrounding fluid, such as tracheal secretions or cerebrospinal fluid.
In contrast to the highly specialized epithelial cilia, almost all cells (with the
exception of a few myeloid and lymphoid lines) can carry primary cilia (also known as
monocilia). As the name suggests, there is only one monocilium per cell, which arises
directly from the mother centriole. Like the cilia found in ciliated epithelia, the axoneme of
primary cilia is constructed on a scaffold consisting of 9 MT doublets. Unlike the
stereotypical arrangement of microtubules, motors and structural proteins found in epithelial
cilia, the contents of monocilia are extremely varied. As such, monocilia can serve different
functions depending on the proteins they are loaded with. For example, by displaying
specialized receptors, these cilia are adapted to function as light photoreceptors in the retina,
or as olfactory receptors in the nose. Primary cilia are also signaling centers at the interface
between the cell and the extracellular environment. For example, they are essential for
hedgehog signaling, and absent or defective cilia in mouse embryos result in a spectrum of
defects including neural tube defects, polydactyly and cardiac defects.26,27
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In the LRO, there are two different types of primary cilia: motile and sensory (Fig. 3).
The motile primary cilia, which populate the center of the LRO, are equipped with dynein
motor proteins, enabling them to create a leftward fluid flow and break LR symmetry. The
non-motile monocilia are more abundant at the lateral edge of the LRO in mouse, and lack
dynein motor proteins, but contain polycystin-2, the product of the gene mutated in type 2
dominant polycystic kidney disease.28 It is a cation channel that is required to sense the flow
generated by the motile monocilia.29 In the presence of leftward LRO flow, polycystin-2
induces an increase in calcium concentration on the left LRO border, and therefore translates
the LRO flow into an asymmetric calcium gradient.28
There is significant evidence to support the model outlined above that 1) flow
generated by LRO monocilia is required for proper LR patterning and 2) that sensory cilia
detect this leftward flow. First, regarding the requirement for motile cilia at the LRO, altered
function (i.e. mutations, knockdown or knockout) of any of a number of ciliary genes
including components of the dynein motor complex or genes necessary for ciliary biogenesis
such as the IFTs results in LR patterning defects.13,30-33 Initial evidence for a role of cilia in
development of LR asymmetry came from study of patients with Primary Ciliary Dyskinesia
(Kartagener syndrome), which manifests as respiratory disease, male infertility and a 50%
incidence of situs inversus.34 Respiratory compromise and male infertility in PCD are due to
defective dynein function in the tracheal cilia and sperm axoneme, while randomization of
SS and SI is secondary to improper LRO motile cilia function. Similarly, mice with a point
mutation in the left-right dynein (lrd) gene, which renders cilia immotile, also have
randomization of SS and SI.30 LRO flow in these mice is absent, but artificial application of
leftward flow across the LRO can re-establish SS, while application of flow to the right can
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induce SI.35 This indicates that LRO flow itself is the event that breaks LR symmetry.
Second, regarding the requirement for sensory cilia at the LRO, mice that lack LRO flow due
to immotile cilia have been shown to lack increased calcium levels on the left border of the
LRO. This is also the case in mice with normal LRO flow that lack the polycystin-2 gene,
indicating that there are no asymmetric calcium levels in the absence of leftward LRO flow,
and that detection of LRO flow requires the presence of the polycystin-2 receptors in the
surrounding sensory cilia.28

I.6. Asymmetric gene expression downstream from the LRO
The result of asymmetric LRO flow is a downstream cascade of asymmetric gene
expression that propagates the asymmetric signal and ultimately results in asymmetric
organogenesis. This cascade is outlined by asymmetric expression of Coco, Nodal, Lefty-1,
Lefty-2 and PitX2, all of which are observed prior to visible asymmetry of heart looping (Fig.
5).
Nodal is a left-side determinant that is initially expressed symmetrically around the
LRO.36-39 It subsequently becomes asymmetrically expressed at both the LRO and the left
lateral plate mesoderm (LPM), a structure lateral to the LRO that later contributes to the
mesenchyme of various visceral organs. Cells in the left LPM that receive Nodal signaling
contribute to various visceral organs, such as the lung and heart, that develop left-side
specific morphologies. On the other hand, in the absence of Nodal expression, both the left
and right LPM specify right-sided organogenesis by default. In normal development periLRO Nodal expression induces its own expression at the left LPM through a positive
feedback loop, thereby changing the default state of the left LPM from right to left-sided
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organ development. With that in mind, complete absence of Nodal expression at both LPMs
leads to the development of right atrial isomerism, while bilateral Nodal expression results in
left atrial isomerism.

Figure 5. Schematic representation of the asymmetric gene cascade. 1. At the LRO,
leftward flow inhibits Coco (shown in yellow) expression on the left but not on the right.
2. Coco inhibits Nodal (shown in dark blue) expression on the right but not the left. 3.
Left-sided Nodal expression at the LRO induces Nodal expression at the left LPM. 4.
Nodal induces its own expression, as well as the expression of Lefty-1 and Lefty-2 (shown
in orange. 5. Lefty-1 and Lefty-2 contain the expression of Nodal to the LPM. 6. Leftsided Nodal expression induces left-sided PitX2 expression (shown in light blue).
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While leftward LRO flow is required for left LPM Nodal expression, Nodal itself
does not directly respond to flow.40 The transition from symmetric to asymmetric Nodal
expression is mediated by Coco – a secreted antagonist of Nodal.41-43 Before LRO flow is
established, Coco and Nodal have overlapping, symmetric, peri-LRO patterns of expression.
Unlike Nodal, Coco is directly inhibited by LRO flow. As a result, Coco is suppressed on the
left, but still maintained on the right. Consequently, Coco releases its negative inhibition of
the co-expressed Nodal protein, such that Nodal becomes asymmetrically expressed on the
left, but not the right.40
Lefty-1 and Lefty-2 are also Nodal inhibitors that are responsible for keeping the
Nodal positive feedback loop in control, and its expression localized to the LPM.44-46 They
are induced by Nodal and are expressed at the midline (Lefty-1) and the left LPM (Lefty-2).
In the absence of either gene, Nodal expression begins normally in the left LPM, but
subsequently leaks to the other side.
The feedback inhibition of Lefty-1 and Lefty-2 not only limits the area of Nodal
expression, but also the time. In the mouse, Nodal expression is present for only 6 hours.
Once Nodal expression at the LPM ceases, it passes on the left-side determinant baton to
another asymmetrically expressed gene PitX2.47-49 PitX2 is induced by Nodal at the LPM.
However, it persists much longer, and once Nodal disappears its expression is maintained by
Nkx2. As a left side determinant, similar to Nodal, complete absence of PitX2 yields right
atrial isomerism, while bilateral presence results in left atrial isomerism.
In this introduction, we have reviewed the roles of ciliary and TGF-beta signaling on
LR development. Another critical pathway for LR patterning is the Notch pathway and is
particularly relevant for the work in this thesis.
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I.7. Molecular basis of Notch signaling
The notch signaling pathway was first identified almost 100 years ago in mutant flies
with “notched” wings.50 It represents a local communication system between neighboring
cells that is evolutionarily conserved and pervasive throughout development. Often
responsible for the development of cell fate boundaries, such as the boundary between the
anterior and posterior drosophila wing, and patterned structures such as the ciliated
epithelium of Xenopus, Notch signaling is involved in a diverse range of biological processes
such as cell-fate specification, self-renewal, differentiation, proliferation and apoptosis.
At the most basic level, the Notch signaling pathway consists of three core
components which were originally discovered in mutant animals that phenocopied Notch
mutants: 1) a Delta-type or Jagged/Serrate family ligand, 2) a Notch receptor, and 3) a CSL
family transcription factor. Different species have a different number of each of these
components. For example, there are four Notch receptors in human and mouse, three in
Xenopus and one in drosophila. However, at least one ortholog of each of the three core
components has been identified in all metazoan organisms studied to date.
The signaling process begins through the interaction of a delta-type or Jagged/Serrate
ligand with a Notch receptor. In the majority of cases Notch ligands act as agonists, where
they induce a complex series of proteolytic cleavages that release the Notch intracellular
domain (NICD), which then translocates to the nucleus and binds to a CSL family
transcription factor to affect target gene transcription. However, both types of ligands have
also been described to act as antagonists of Notch signaling, although the mechanism of
action is not as clearly understood as that for Notch activation.51-57 It appears to be strictly
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cell autonomous, such that cells expressing high levels of ligand can activate Notch signaling
in neighboring cells, but prevent Notch activation in the cell they are expressed in.
Both Delta, Jagged/Serrate and Notch are single pass transmembrane proteins, with
extracellular domains that contain arrays of multiple epidermal growth factor (EGF) - like
repeats that mediate the interaction between the two proteins.58 Next to the EGF repeats,
Notch receptors also contain a negative regulatory region (NRR) and a heterodimerization
(HD) domain, which serves to prevent Notch cleavage in the absence of ligand.59 The full
length Notch protein matures in the secretory pathway where it is cleaved by furin proteases
at the S1 site located within the HD domain.60,61 Subsequently, it is reassembled into a
functional heterodimeric receptor at the cell surface where it is held together by non-covalent
interactions.
The intricate process of Notch receptor activation and NICD release involves a series
of four proteolytic cleavage events termed S1, S2, S3 and S4. Following interaction with a
Notch ligand, the NECD-ligand complex gets endocytosed by the ligand-expressing cell,
thereby applying a mechanical force that results in dissociation of the NECD/Notch
transmembrane complex. The dissociation exposes the S2 site, which is located 12 amino
acids proximal to the transmembrance domain of NTMIC,62-64 thus enabling cleavage of the
S2 site by ADAM10 or ADAM17 metalloproteases, which create a membrane tethered
intermediate Notch extracellular truncation (NEXT).65 Finally, a  𝛾-secretase complex
(composed of presenilin-1or -2, Aph1, Pen2, and Nicastrin) first cleaves the S3 site within
the transmembrane domain, and then the S4 site, thereby releasing the NICD.66,67
Once released NICD translocates to the nucleus where it interacts with CSL, a family
of sequence specific DNA binding proteins. In an unbound state, CSL proteins act as co-

17
repressors,68 but once bound to NICD, they transform into co-activators.69 This is achieved
through distinct CSL co-activator and co-repressor complexes that are coordinated by NICD,
such that in the absence of NICD CSL proteins associate with co-repressors, whereas in the
presence of NICD they associate with co-activators. The use of co-repressor/co-activator
complexes also allows for cell-type and time specific Notch signaling by requiring additional
co-factors that are specific for different Notch target genes.
This type of Notch signaling control can lead to unexpected and counterintuitive
results during experimental manipulation. A decrease in Notch signaling via knockdown or
knockout of Notch components would be expected to lead to lower expression of Notch
target genes, as has been observed in Notch mutants. However, CSL mutants can have a
milder phenotype than Notch mutants, because of the cancelling effects of removing both the
co-repressive and co-activating function of CSL proteins. In some cases, CSL mutants have a
higher level of Notch target gene expression because of dual regulation by both CSL
proteins, as well as other transcription factors that become upregulated when Notch signaling
is compromised.70 Similar results have been observed in Notch ligand mutants where the
dominant action of the ligand is as an antagonist and not agonist.51-57 Finally, overexpression
of NICD leads to ectopic expression of Notch target genes only sometimes, because certain
Notch target genes require additional co-factors (that may be lacking in ectopic tissues) for
proper CSL co-activator complex function.71,72

I.8. Notch forms cell boundaries and patterned structures
While Notch signaling is used for many different cell-fate decisions, most instances
fall into one of three categories: lateral inhibition, decisions on cell lineage and inductive
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signaling.73-76 Lateral inhibition yields a “dotted” pattern of a particular cell fate among a
surrounding group of cells of a different cell fate, as seen, for example, on the surface of the
ciliated frog epidermis. A group of equipotent cells signal to each other via Notch signaling
to inhibit each other from adopting a specific cell fate. In the case of the ciliated frog
epidermis, a ciliated cell ends up expressing greater quantities of Notch ligand, which
induces Notch signaling in neighboring cells that inhibits cilia formation. Additionally, it also
leads to down-regulation of Notch ligand in the surrounding, non-ciliated cells, in order to
prevent induction of Notch signaling in the ciliated cell.
Lineage decisions typically occur through asymmetric cell divisions. One daughter
cell has activated Notch signaling, while the other does not. As a result the two cells adopt
different cell fates. Finally, inductive signaling is often responsible for the creation of
borders, such as the border between the anterior and posterior portions of the drosophila
wing. One group of cells of a distinct lineage signals a bordering group of cells and
“induces” a different cell fate, thereby creating a border.77 The border is maintained through
unidirectional Notch signaling and feedback loops, similar to the scenario described in lateral
inhibition. One group of cells expresses a high level of Notch ligand and receives very little
Notch signaling, while the neighboring group of cells has a high level of Notch signaling that
induces a different cell fate, and inhibits expression of Notch ligand.

I.9. Regulation of Notch signaling via glycosylation
While most extracellular proteins undergo N-linked glycosylation, the extracellular
domain of Notch also undergoes a unique form of O-linked glycosylation that is essential for
Notch signaling and its modulation. Two different types of O-glycosylation have been
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observed on Notch, either with O-linked glucose or O-linked fucose. While the significance,
if any, of O-linked glucose is still unclear, O-linked fucose can influence Notch signaling.7880

O-glucoylation and O-fucosylation were first discovered on a different class of
proteins that, like Notch, also carry repeating EGF domains – serum glycoproteins that are
involved in regulating blood clotting and fibrinolysis.81 This led to the observation that the
extracellular domain of Notch also carries O-glucose and O-fucose, which can then extended
by glycosyltransferases to form trisaccharide and tetrasaccharide chains, respectively.82 The
initial glycosylation of Notch by O-fucose is essential for Notch signaling, while the
subsequent addition of the second, third and fourth sugars is not required, but can modulate
the sensitivity of the Notch receptor to different ligands.
The enzyme O-FucT-1, encoded in mammals by the gene protein Ofucosyltransferase 1 (POFUT1), catalyzes the initial addition of O-fucose to an EGF
domain.83,84 There is a single POFUT1 gene in mammals, C. elegans, and Drosophila.84 OFucT-1 requires a properly folded EGF domain as a substrate. O-fucosylation then occurs at
a single unique residue, within a loose consensus sequence.83-87 The first indication of this
process came after the observation that there is decreased expression of a Notch reporter gene
in cells that are deficient in GDP-fucose, the substrate used by O-FucT-1.88,89 It was
subsequently demonstrated that mutation or knockdown of Ofut1 in Drosophila results in
complete loss of Notch signaling, with phenotypes as severe as those in mutants with
completely absent Notch receptor.90-92 In mice, Pofut1 mutants phenocopy mutants for the
only murine CSL gene,93 or double mutants for the two murine presenilin genes,94,95 which
are required for the proteolytic processing of Notch and subsequent NICD release.
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Interestingly, the mouse Pofut1 mutant phenotype is more severe than the phenotype
observed for single Notch mutants (mouse has four different types of Notch receptors),
indirectly indicating that O-fucosylation is required for the function of all Notch receptors.
Detailed phenotypic analysis has also shown that O-fucosylation is required for all three
main modes of Notch signaling: lateral inhibition, cell-lineage decision and inductive
signaling. Finally, rather than simply being a permissive factor that is required for proper
Notch signaling, recent evidence suggests that regulation of the distribution of O-FucT-1
controls the pattern of Notch activation. Even though both the Drosophila Ofut1 gene and the
murine Pofut1 gene are broadly expressed, the mRNA transcripts are tightly regulated both
spatially and temporally.84,90,96 Ectopic expression Ofut1 in Drosophila and OFUT1 in cell
culture has been observed to have both positive and negative effects Notch signaling,
indicating that transcriptional regulation of Ofut1 itself modulates Notch signaling.90-92
Following the addition of O-fucose to an EGF domain on Notch, the monosaccharide
can be elongated to a disaccharide by Fringe. Initial evidence that Fringe may be involved in
the synthesis of O-glycans on Notch came from observations that 1) bioinformatically, there
is a weak similarity between Fringe and a bacterial galactosyltransferase, lex-1,97 2) Fringe
influences the Notch pathway,98-100 and 3) Notch contains consensus sequences for O-glycan
modifications.82,101 Biochemical characterization confirmed that Fringe catalyzes the second
step in the synthesis of the O-fucose tetrasaccharide found on Notch EGF domains by
transferring a GlcNac onto fucose in a 1,3 linkage.88,102 Fringe uses fucose-O-EGF as a
substrate, and prior fucosylation of the EGF domain by O-FucT-1 is required for proper
Fringe activity. Like O-FucT-1, Fringe also has a preference for specific EGF domains,88,103
and can glycosylate both the Notch receptor and Notch ligands.86,88,102 It contains a highly
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conserved DXD motif that is known to be essential for enzymatic activity in other
glycosyltransferases.104 Mutation of this motif eliminates the enzymatic activity of Fringe
both in vivo and in vitro.88,89,102,105 The ability of Fringe to influence Notch signaling is
impaired in cells that are deficient in the synthesis of fucose-containing glycans, indicating
that Fringe requires a fucose substrate.88,89 Mutation of the gene fringe connection, which
encodes a transporter for UDP-GlcNAc, the Fringe donor sugar, phenocopies fringe
mutants.106,107 This data conclusively demonstrates that Fringe is a glycosyltransferase that
influences Notch signaling.
Fringe activity is both ligand and receptor specific. In general, Fringe acts as a
positive regulator of Delta signaling and a negative regulator of Serrate/Jagged signaling,
although there are exceptions that have been found in human cell culture experiments. In the
Drosophila wing, Fringe potentiates the ability of Delta to activate Notch,98 and at the same
time inhibits the ability of Serrate to activate Notch.98-100 Similarly, in cultured human tissue
cells, Lunatic Fringe increases the signaling from Delta1 to Notch1,108 and decreases the
signaling from Jagged1 to Notch1.88,89,108 However, Lunatic Fringe has been reported to
potentiate the signaling of both Delta1 and Jagged1 to Notch2,108 while another study
reported decreased signaling by Jagged1 to Notch2, and no effect of Delta1 signaling to
Notch2.109
Unlike O-FucT-1 activity, which is required for all three major modes of Notch
signaling (lateral inhibition, cell-lineage decision and inductive signaling), Fringe appears to
only affect inductive signaling.100,110 This is best illustrated by its effects on Drosophila wing
development, where Fringe creates a stripe of Notch signaling at the border of the anterior
and posterior wing through opposing effects on Delta and Serrate.51,111
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Even though O-linked glycans exert their influence on Notch activation at the cell
surface, the actual act of glycosylation occurs in the Golgi. This is supported by two lines of
evidence. First, a chimeric version of Fringe that is retained in the Golgi acts normally102
while a secreted form has no activity, and second, the nucleoside sugar donors like GDPfucose or UDP-GlcNAc are synthesized in the cytoplasm and then transported into the Gogli
by transporters such as Fringe connection.106,107 As a result, the extracellular concentration of
the nucleoside sugar donors is too low to support glycosylation of Notch in its
transmembrane location.

I.10. Notch involvement in LR development
Notch appears to be involved in the regulation of several keys steps of the LR
developmental cascade. To date Notch has been implicated in LRO morphogenesis, LRO
ciliary length control, symmetric peri-LRO Nodal expression, asymmetric Nodal expression
at the left LPM, and asymmetric PitX2 expression at the left LPM.
In mouse, concomitant loss of Dll1 and Baf60c, which binds to CSL and recruits the
CSL co-activator complex, leads to disruption of the organization of the node.112-114 In
zebrafish, increased Notch signaling by overexpression of NotchICD and deltaD resulted in
longer cilia via foxj1a.115 Alternatively, decreased Notch signaling using mutant deltaD, a
homologue of Dll1, led to shorter cilia and slow fluid flow in the LRO. However, Dll1 null
mice have been shown to have normal leftward LRO fluid flow.112 Thus, the role of Notch
signaling in LRO ciliogenesis and ciliary length control remains unclear.
In mice, Dll1 or Notch1/Notch2 double mutants have defects in laterality secondary to
suppression of symmetric peri-LRO Nodal expression.112,114,116 Symmetrically expressed
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Nodal at the periphery of the LRO is required for left specific Nodal expression at the
LPM.117,118 There are two specific enhancers for Nodal expression. Symmetric peri-LRO
Nodal expression is regulated by an enhancer in the upstream region of the Nodal gene, while
left-sided LPM Nodal expression is regulated by an enhancer of Nodal found within intron
1.119,120 The LRO specific enhancer contains two CSL-binding sites, which are functionally
important for peri-LRO Nodal expression.112,116 Additionally, Peri-LRO Nodal expression
was also not detected in RBPjk (CSL) deficient mice.116 Similar results have been obtained in
zebrafish116 and Xenopus.121
In zebrafish, expression of cyclops and spaw, two Nodal-related genes, at the left
LPM is regulated by Notch signaling, although it appears that the two genes are regulated by
different mechanisms. Increase in Notch signaling resulted in randomized expression of both
genes at the LPM, but increased peri-LRO expression only for Cyclops.116,122 Alternatively,
decrease in Notch signaling by a ɣ-secretase inhibitor suppressed the expression of charon, a
Cerebrus/Dan family member responsible for blocking transfer of spaw from the LRO to the
right LPM.42,123 As a result, lack of charon led to randomization of Nodal expression at the
LPM.122
Dll1 has been reported to be asymmetrically expressed in chick, but not in other
vertebrates, including mice and Xenopus.112,121,124 Asymmetric Dll1 expression, and
subsequent asymmetric Nodal expression is inhibited with omeprazole, a pharmacologic
inhibitor of H+/K+-ATPase, indicating that H+/K+-ATPase activity could be responsible for
asymmetric regulation of Notch signaling and LR axis formation in the chick LRO.124 To
date no LRO flow has been detected in the chick. Given that asymmetric Dll1 expression
appears to be unique to the chick, it is plausible that the chick LR developmental cascade
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may have diverged from that of other vertebrate model organisms, with Notch signaling
providing a unique mode of LR axis formation.
Finally, in Xenopus Notch signaling has recently been implicated in PitX2 expression
at the LPM through the action of the transcriptional repressor B-cell lymphoma 6 (BCL6)
and its co-repressor BCL6 co-repressor (BCoR).121 Repression of Notch signaling by BCL6
and BCoR is required to allow PitX2 expression at the left LPM. Knockdown of either BCL6
and BCoR resulted in abnormal heart looping, abnormal PitX2 expression at the LPM, but
normal expression of Xnr1, a homologue of Nodal, at the left LPM.
Altogether, there is convincing evidence that Notch signaling is involved in the
regulation of peri-LRO expression of Nodal, and asymmetric expression of PitX2 at the left
LPM. However, there is conflicting evidence from different model organisms whether Notch
signaling is involved in LR axis development via asymmetric Dll1 expression, or whether it
is involved in the regulation LRO ciliary length, and left specific expression of Nodal at the
LPM. In my work, I identify yet another mechanism for notch signaling at the LRO which
unites ciliary cell fate, ciliary flow, and asymmetric nodal activation providing a simple
mechanism for the relation between notch signaling and nodal activation. I obtained this
result by the analysis of a novel gene, Galnt11, identified from a patient with heterotaxy, that
has an important new role in notch signaling.

I.11. Genetics of heterotaxy
The genetics of human heterotaxy is characterized by two salient features: a high
degree of locus heterogeneity combined with tremendous phenotypic variability.2 In
addition, the complexity of the associated heart disease results in a high degree of lethality
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prior to reproductive age, thus limiting the number of extended pedigrees.125,126 Familial
cases of heterotaxy have shown tremendous phenotypic variability within many heterotaxy
pedigrees, with the co-existence of situs solitus, situs inversus and isomerism syndromes
within one family. Although these features complicate attempts to delineate the genetic
contributions to heterotaxy, the wealth of gene information gleaned from studies of left-right
development in model organism systems provides a singular opportunity to dissect the
underlying genetic etiology.
At the current time, gene mutations have been associated with 10-20% of cases of
heterotaxy.127,128 These can be divided into syndromes with a known genetic etiology that
have heterotaxy as an associated feature and isolated heterotaxy cases with an identified
single-gene mutation. Consistent with the prominent role cilia play in the development of
LR asymmetry, syndromes associated with defects in cilia structure and function can
manifest with heterotaxy as part of the clinical spectrum (Table 1).

Primary Ciliary Dyskinesia
The syndrome with the most prominent association with heterotaxy is Primary Ciliary
Dyskinesia (PCD or Kartagener syndrome). PCD consists of sino-pulmonary disease, male
infertility and a 50% incidence of abnormal cardiac situs.34 A minimum of 6.5% of patients
with PCD have intracardiac disease consistent with heterotaxy.129 PCD is caused by
mutations in genes affecting function of motile cilia in the airway, the sperm flagellum and
the motile cilia found on the left-right organizer during development. At this time, defects in
12 distinct genes have been associated with PCD (Table 1), and the repertoire is increasing as
genomic analysis of affected patients becomes more sophisticated. Inheritance is
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predominantly recessive, although rare dominant and X-linked pedigrees have been
identified.

Bardet-Biedl Syndrome
Bardet-Biedl syndrome is a rare genetic disorder characterized by renal and hepatic
cystic disease, retinitis pigmentosa, polydactyly, developmental delay and obesity. The
cardiac manifestation is rare and shows situs inversus. 14 BBS genes have been identified to
date, and they all focus on biogenesis and function of the centriole upon which the cilium is
built.
Other syndromes that have been classified as “ciliopathies” also include cardiac
disease that is part of the heterotaxy spectrum.130 These include Meckel-Gruber syndrome,
Short-Rib Polydactyly Syndrome and Ellis-van Creveld Syndrome. Ellis-van Creveld
syndrome is a skeletal dysplasia associated with a high incidence of common atrium and
systemic and pulmonary venous anomalies that are frequently seen in the context of Htx.
Mutations in two genes, EVC and EVC2 underlie approximately 70% of cases; EVC and
EVC2 interact at the cilium to affect hedgehog signaling.131 Dextrocardia has been seen in
the context of VACTERL-H syndrome, and one possible molecular etiology for VACTERLH is a deletion encompassing the Zic3 gene, which also causes X-linked non-syndromic
heterotaxy.132
Table 1. List of syndromes involving heterotaxy and associated gene mutations
Syndrome

Primary Ciliary

Cardiac

Other clinical

Gene(s) and

Molecular/Cellular

Disease

Features

References

Ontology

DNAI1,

Structure and function of

Situs Inversus Chronic sinusitis,
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Dyskinesia

Totalis

bronchiectasis,

DNAI2,

(PCD)

(50%),

neonatal respiratory

DNAH5,

Heterotaxy

distress, male

DNAH11,

(6.5%)

infertility

RSPH9,

Occasional: female

RSPH4A,

infertility,

LRRC50,

retinopathy

RPGR,

motile cilia

TXNDC3,
KTU, CCDC40,
CCDC39,
Bardet-Biedl

Rare situs

Renal

BBS1,2,4,5,7-

Centriole/Basal body

Syndrome

inversus, up

abnormalities,

10,12

structure and function

(BBS)

to 50% with

polydactyly, retinal

Arl6(BBS3) ,

minor cardiac

dystrophy, hearing

TRIM32

abnormalities

loss, obesity,

(BBS11) ,

developmental

BBS14

delay,
hypogonadism,
Meckel-Gruber

20% CHD

Encephalocele,

MKS1,

Primary Cilium and

Syndrome

including rare

polydactyly,

TMEM216

basal body

situs inversus

polycystic kidneys,

(MKS2),

hepatic

TMEM67

abnormalities

(MKS3),

28
RPGRIP1L,
CC2D2A
Nephronopthisis

Situs

Cystic kidney

NPHP1, INVS

Cilium, Centriole, Cell

inversus,

disease, retinal

(NPHP2),

cycle

VSD

degeneration

NPHP3,
NPHP4,
NPHP5,
CEP290,
(NPHP6),
GLIS2,
(NPHP7) ,
NEK8 (NPHP8)

VACTERL-H

VSD,

Vertebral

Dextrocardia

anomalies, anal

(rare)

atresia,

Zic3

Unknown

EVC1, EVC2

Hedgehog signaling,

tracheoesophageal
fistula, limb
abnormalities,
hydrocephalus,
renal hypoplasia
Ellis-Van-

Atrio-

Short ribs,

Creveld

venytricular

polydactylay,

Syndrome

canal,

ectodermal

cilium
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Common

dysplasia, renal

Atrium,

abnormalities

LSVC

I.12. Non-syndromic heterotaxy and the role of CNVs in causative heterotaxy genes
A major limitation in identifying causative genes in heterotaxy is the paucity of
families segregating highly penetrant alleles, and the high locus heterogeneity, which has
limited the ability to map disease loci. Because of marked impairment in reproductive fitness,
some fraction of heterotaxy could be caused by very rare, highly penetrant, dominant
mutations. Although such mutations have historically been difficult to identify, recent
advances have improved the ability to detect these. For example, the use of quantitative
interrogation of dense sets of SNPs has dramatically improved the ability to detect small
copy number variants (CNVs). The significance of such rare mutations can be difficult to
establish in the setting of high locus heterogeneity, as is the case for heterotaxy, where
discovering a second hit in the same gene in a small cohort is unlikely.
This obstacle has recently been overcome by using X. tropicalis as a high-throughput
model system to test the validity of rare genes identified through CNVs.133 X. tropicalis has a
mechanism of LR development that is highly conserved throughout vertebrate species, can
produce large numbers of embryos that complete asymmetric heart and gut looping in a short
time frame (4-5 days), and has a relatively compact diploid genome that retains substantial
synteny to human, simplifying the identification of orthologous genes.12,15,134 High-resolution
genotyping of 262 heterotaxy subjects and 991 controls revealed 38 small CNVs that
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encompassed 61 genes, 38 of which have X. tropicalis orthologs (in the most recent genome
assembly, 22 in the previous genome assembly). 7 genes had favorable in situ expression
patterns in ciliated organs and/or the heart, and 5 of them affected LR development when
knocked down with MO. One of the five genes identified was Galnt11, a putative

Galnt11

glycosylation factor that has not been characterized previously.133

Figure 6. Deletion of Galnt11 in a patient with heterotaxy. Genes located in the segment
are shown at the top, followed by the results of Illumina genotyping in the middle, and
qPCR at the bottom of the figure. Both genotyping and qPCR results indicate a deletion in
the first 3 exons of GALNT11.
I.13. Galnt11
Galnt11 is part of a family of twenty distinct GalNAc-transferases (Galnts), which
play an essential role in O-GalNAc glycosylation in eukaryotes. O-GalNAc glycosylation is
found on more than 10% of human proteins and more than 50% of the proteins passing
through the secretory pathway.135,136 This process of O-GalNAc sugar chain addition to
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proteins is catalyzed by a complex set of enzymes localized at the Golgi apparatus.137,138 The
Galnt family catalyzes the first step of this cascade where they add a GalNAc residue onto
Ser/Thr amino acids in proteins.139,140 Following the addition of a GalNAc residue, different
core-forming enzymes generate various core O-glycan structures, which can themselves then
be further extended before being capped with histo-blood group-related structures or sialic
acid.141 Extensive in vitro studies have identified various substrates for Galnt enzymes.
Members of the family appear to have different, but somewhat overlapping, substrate
specificity.141,142 However, direct in vivo protein targets have only been identified for several
Galnt enzymes. In humans, Galnt3 is required for O-glycosylation of a specific site in
fibroblast growth factor 23 (FGF23) that prevents proprotein convertase inactivation of
FGF23, and loss of Galnt3 function leads to familial tumoral calcinosis.143,144 Galnt2 appears
to O-glycosylate a specific proprotein convertase site in angiopoietin-like protein 3 that is
involved in in maintaining normal levels of plasma lipids.145-148 In mice, Galnt1 is necessary
for O-glycosylation of osteopontin and bone sialoprotein.149 Finally, in Drosophila Galnt3 is
important for O-glycosylation of the integrin-binding ligand tiggrin, which plays an essential
role in the adhesion of dorsal and ventral cell layers in the basal matrix of the Drosophila
wing.150 However, to the best of our knowledge, to date there have been no in vivo protein
targets identified for Galnt11.
I set out to discover the function of Galnt11 in LR patterning. Prior to my studies, we
knew that Galnt11 was strongly expressed in the kidney (a ciliated structure) and that
knockdown of Galnt11 led to LR defects recapitulating the human disease, heterotaxy.
However, other than sequence relation to a family of GalNAc-transferases no functional role
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for Galnt11 had been identified, the mechanism of Galnt11 in LR patterning was unknown,
and no known targets of galnt11 had been identified.
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II. HYPOTHESIS
Galnt11 is a GalNAc-transferase that is necessary for proper left-right axis
establishment and heart looping. Its function is to specify between motile and sensory cell
fates at the Left-Right Organizer by glycosylating Notch receptor and modifying Notch
signaling.
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III. METHODS
III.1. In vitro fertilization and embryo injection
In vitro fertilization was performed according to Khokha et al.151 Briefly, male and
female frogs were primed with 20 units of human chorionic gonadotropin (hCG; Chorulon)
12-36 hours before IVF. A boosting dose of 200 units hCG was injected 3–4 hours before
IVF. Crushed male testes and female eggs were mixed in dishes coated with standard 1x
MBS solution with 0.1% bovine serum albumin (BSA), and subsequently allowed to fertilize
in 0.1x MBS solution (pH = 7.8–8.0). Once fertilized, the one-cell embryos were de-jellied
using 3% cysteine in 1/9x MR (pH = 7.8–8.0), washed with 0.1x MBS, and put at 20 °C in a
3% Ficoll in 1/9x MR solution to retard the cell division process.
Embryos were injected at the 1- and 2-cell stage using an Narishige microinjection
apparatus. Drop size was calibrated to 8nl per injection using micrometers to measure
diameter of droplet. Injection doses for both MO and RNA were titrated to minimize toxicity.
Following injection, embryos were allowed to rest for one hour at room temperature.
Normally dividing embryos were then sorted and allowed to develop in 1/9x MR with 1x
gentamycin (100 µg/ml) at 22-28 °C, depending on desired development rate.

III.2. MO design
Morpholino oligonucleotides were designed against the start and splice site of X.
tropicalis Galnt11 (start site MO sequence 5’ to 3’: GCGCTGCCCATCGTCCCCCTAGCA
T; splice site MO sequence 5’ to 3’: AGTAGGTGCCCTTCTCTCTGACCTG), as well as
against the start site of X. tropicalis Notch1 (sequence 5’ to 3’: GAACAAGCAGCCCGATC
CGATACAT).
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III.3. Heart looping scoring
Following injection of MO or RNA, X. tropicalis embryos were incubated at 28 °C
until they reached Nieuwkoop and Faber (NF) stage 45. Tadpole hearts were scored as either
D-looped, for normal outflow tract looping from right to left, L-looped, for mirror image
looping from left to right, or A-looped, for hearts that lacked either D- or L-looping (Figure).

III.4. GRP dissection
Neurula stage X. tropicalis embryos were used to dissect the GRP according to Blum
et al.15 All dissections were performed in 0.1x MBSH in agarose-coated plates. A transverse
cut perpendicular to the AP plane was used to open the embryo. At this point the gastrocoel
cavity was visualized, with the neural folds being positioned dorsally, and located ventrally.
The left and right edges of the gastocoel cavity were then dissected towards the posterior tip
of the embryo until the two dissection planes met and the ventral yolk side was removed.

III.5. In situ hybridization
Whole mount embryos and dissected GRPs were fixed in MEMFA for 1-2 hours. If
LacZ/RedGal staining was used, embryos were fixed in MEMFA for 1 hour, followed by
staining in RedGal mix (variable time, until red stain appears), followed by re-fixation with
MEMFA for 1 hour. Digoxigenin-labeled (Roche) RNA probes were prepared from
linearized plasmids using SP6 or T7 RNA polymerase (Ambion, NEB respectively) We used
a standard X. tropicalis whole-mount in situ hybridization protocol.
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III.6. Immunohistochemistry
Whole mount embryos and dissected GRPs were fixed in 4% paraformaldehyde
(PFA) in 1x PBT solution for 1 hour, followed by cold ethanol fixation at 4 °C for 4 hours. If
the embryos had been injected with GFP or RFP, they were fixed in 4% PFA in 1x PBT
solution for 4 hour with no cold ethanol fixation. Primary antibodies used were mouse
monoclonal antibody directed against acetylated alpha tubulin (1:1000; Sigma), mouse
monoclonal antibody directed against Galnt11 (1:1).139
Fixed embryos and GRPs were permeabilized with 0.2% Triton in PBS (PBT),
blocked in 2% BSA in PBT, and subsequently incubated with primary antibodies and Texas
red- and Alexa Fluor 488-conjugated secondary antibodies (Invitrogen). Embryos were
mounted in Pro-long antifade (Invitrogen) and imaged on a Zeiss Axioskop.

III.7. Electron microscopy
Whole mount embryos and dissected GRPs were quickly washed in 1x PBS (Ca2+
free) with 1mM EDTA and fixed in 2.5% glutaraldehyde, 50mM Hepes, 2mM MgI and 1mM
EDTA for one hour at room temperature, followed by one hour at 4 °C. The samples were
then washed with 50mM Hepes and delivered to the Yale Electron Microscopy Laboratory
for further processing.

III.8. Video-tracking of tadpoles
Embryos were unilaterally injected at the 2-cell stage with 1.0ng Galnt11 MO and
Alexa Fluor 488 lineage tracer (Invitrogen). Specimens were raised to stage 32 in 1/9x MR +
Gentamycin. To circumvent muscle contractions (active swimming), which would
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compromise cilia-based motion, embryos were anesthetized with benzocaine. After
validation of unilateral lineage tracer expression, embryos were placed individually in
agarose-coated Petri dishes with 1/9x MR + benzocaine. Embryo motion was recorded for 10
min at 0.1 fps using a Canon EOS 5D MarkII and DSLR Remote Pro 1.3 (Breeze Systems).
Subsequently, each embryo was flipped over to the other side and motion was similarly
recorded. Movies were analyzed using ImageJ (NIH). Individual images were superimposed
onto each other to create a path line that was used to calculate the total distance travelled.
Embryos which showed no movement or movement that was interrupted artificially (e.g.
caused by unevenness of the agarose) were excluded from the analysis. The uninjected side
served as internal control. Determination of statistical significance was performed by
Wilcoxon matched pairs test (Microsoft Excel).

III.9. Roles
All work presented in this thesis was performed by the author, Marko T. Boskovski.
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IV. RESULTS
IV.1. Galnt11 is required for proper heart looping
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Figure 7. Knockdown of Galnt11 with a start- and splice-site MO results in a significant
number of looping abnormalities, compared to uninjected control. These looping
abnormalities can be rescued by coinjection of Galnt11 splice-site MO and human
GALNT11 RNA. Overexpression with GALNT11 RNA also produces abnormal looping.

To determine whether knockdown or overexpression of Galnt11 affects proper LR
axis formation, we injected a start-site Galnt11 MO, a splice-site Galnt11 MO and
GALNT11 RNA at the one-cell stage, and examined the resulting embryos for heart looping
defects at NF stage 45. Uninjected control embryos had 2.9% looping abnormalities (1.1%
A-loops and 1.8% L-loops, n = 252). By contrast, start-site Galnt11 MO injected embryos
had 22.8% looping abnormalities (22.1% A-loops and 0.7% L-loops, n = 145), splice-site
Galnt11 MO injected embryos had 27.9% looping abnormalities (26.5% A-loops and 1.5%
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L-loops, n = 223), and GALNT11 RNA injected embryos had 37.3% looping abnormalities
(15.7% A-loops and 21.6% L-loops, n = 187) (Fig. 6). This suggests that a very specific dose
of Galnt11 transcript is required for proper LR axis development, and that either knockdown
or overexpression leads to heart looping defects.

IV.2. Galnt11 MO induced heart looping defects can be rescued with human GALNT11
RNA
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Figure 8. Looping abnormalities induced by Galnt11 MO can be rescued with human
GALNT11 RNA in a dose dependent fashion.
The similarity in phenotypes between the start- and splice-site Galnt11 MOs
suggested that both MOs are specific. To test this more rigorously, we attempted to rescue
the Galnt11 splice-site MO with a human GALNT11 RNA construct by injecting a constant
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dose of 0.5ng of MO and titrating the GALNT11 RNA dose. Compared to 31.4% looping
defects (26.5% A-loops and 1.5% L-loops, n = 93) after injection of Galnt11 MO only, coinjection of Galnt11 MO with 25pg of GALNT11 RNA resulted in 30.4% looping defects
(15.2% A-loops and 15.2% L-loops, n = 96), co-injection of Galnt11 MO with 12.5pg of
GALNT11 RNA resulted in 13.3% looping defects (7.2% A-loops and 6.0% L-loops, n =
119), and co-injection of Galnt11 MO with 6.25pg of GALNT11 RNA resulted in 4.2%
looping defects (0% A-loops and 4.2% L-loops, n = 103) (Fig. 7). This demonstrates that the
splice-site Galnt11 MO is specific and can be rescued in X. tropicalis with a human
GALNT11 construct. All other experiments requiring knockdown of Galnt11 were
performed using the Galnt11 splice-site MO.

IV.3. Galnt11 affects Coco and PitX2 expression
To test where along the LR axis developmental pathway Galnt11 acts, we looked to
see if abnormal levels of Galnt11 lead to abnormal Coco or PitX2 expression patterns using
whole mount in situ hybridization. Coco is the earliest asymmetrically expressed gene in the
LR cascade where the right side has stronger expression than the left, and PitX2 is the last
asymmetrically expressed gene before asymmetric organogenesis. PitX2 is normally
expressed at the left LPM and not the right. As expected uninjected control embryos had only
4.5% abnormal PitX2 expression (0% expression on the right side only; 2.2% absent
expression on either side; 2.2% bilateral expression, n = 69) (Fig. 8). However, Galnt11 MO
injected embryos had 22.2% abnormal PitX2 expression (0% right side only; 14.8% absent;
7.4% bilateral, n = 64), and GALNT11 RNA injected embryos had 29.4% abnormal PitX2
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expression (8.8% right side only; 2.9% absent; 17.6% bilateral, n = 69), indicating that
Galnt11 acts upstream of PitX2.
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Figure 9. Both Galnt11 MO and GALNT11 RNA yield abnormal Coco and PitX2
expression patterns.
For Coco expression, GRPs from uninjected control embryos also had low percentage
of abnormal expression (95.2% right greater than left; 4.8% right equal to left; 0% left
greater than right; 0% no expression, n = 33). Galnt11 MO injected embryos had 20.9%
abnormal Coco expression (20.8% R = L; 0% L > R; 0% no expression, n = 32), and
GALNT11 RNA injected embryos had 39.1% abnormal Coco expression (21.7% R = L;
13.0% L > R; 4.3% no expression, n = 37), indicating that Galnt11 also acts upstream of
Coco. Since Coco is asymmetrically expressed in direct response to LRO flow, abnormal
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Coco expression in the presence of abnormal Galnt11 levels suggests that Galnt11 is
involved either in the process of flow generation or flow sensation.

IV.4. Galnt11 is expressed in the X. tropicalis GRP and kidneys, and Galnt11 protein is
present in the mouse node
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Figure 10. Immunofluorescence pictures demonstrating that Galnt11 localizes to the
crown cells surrounding the pit cells in the LRO. A. The mouse LRO with cilia in red and
no Galnt11. B and C. The mouse LRO with cilia in red and Galnt11 in green. D-F. Close
up of the border between the crown and pit cells where Galnt11 localizes.
Given that Galnt11 appears to be acting at the level of the LRO where asymmetric
flow is created and sensed, we hypothesized that Galnt11 would be expressed during X.
tropicalis stages 14 – 20 when the LRO cilia form and start functioning to break LR
asymmetry. Whole mount and GRP in situ hybridization of wild type embryos during these

43
stages revealed strong Galnt11 expression during stages. Interestingly, during later stages
Galnt11 was also strongly expressed in the kidneys, which is another ciliated organ like the
LRO. We also used a mouse monoclonal antibody against Galnt11 in E8.0 mouse embryos.
Galnt11 protein was strongly present in the crown cells surrounding the pit cells of the LRO
(Fig. 9), further suggesting that Galnt11 affects LRO cilia.

IV.5. Galnt11 is only required on the left side for proper heart looping
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Figure 11. Only injection of Galnt11 MO on the left produces heart looping defects.
To further investigate the role of Galnt11 in LR axis formation, we exploited an
experimentally useful property of Xenopus – at the two-cell stage, one of the two cells
approximates the left side of the developing tadpole, while the other cell approximates the
right side. This allowed us to test whether Galnt11 is required on the left, right, or both sides
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for proper heart looping. When we injected Galnt11 MO on the right there were 26.2% heart
looping defects (23.8% A-loop, 2.4% L-loop, n = 144), while when we injected Galnt11 MO
on the left there were 5.3% heart looping defects (3.9% A-loop, 1.3% L-loop, n =121) (Fig.
10), indicating that Galnt11 is only required on the left side for proper heart looping.

IV.6. Galnt11 does not appear to affect the ultrastructure of epidermal cilia

Figure 12. Transmission electron microscope images of uninjected control and Galnt11
morphant embryos reveal no differences in ciliary ultrastructure.
Since Galnt11 is strongly expressed in ciliated organs like the GRP and the kidneys,
we wondered whether knockdown of Galnt11 would lead to abnormalities in the
ultrastructure of cilia which we can study with electron microscopy. The epidermis of X.
tropicalis is ciliated, with several hundred cilia present on ciliated epidermal cells
interspersed relatively evenly among non-ciliated epidermal cells. Scanning electron
microscopy revealed no differences between cilia clumps on uninjected control embryos and
those injected with Galnt11 MO. Transmission electron microscopy also revealed no
differences, and cilia on Galnt11 MO injected embryos had a normal arrangement of nine
microtubule pairs with outer and inner dynein arms, and a central microtubule pair in the
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middle (Fig. 11). However, lower magnification SEM images suggested that the cilia clump
density of Galnt11 MO injected embryos might be higher than that of uninjected control
embryos.

IV.7. Galnt11 and Notch1 affect epidermal cilia density
To more closely evaluate whether Galnt11 influences cilia-clump density at the
epidermis, we again performed two-cell injections with Galnt11 MO or GALNT11 RNA,
and compared the injected side with the uninjected. GFP was co-injected as a tracer, and the
cilia were labeled fluorescently with anti-acetylated tubulin antibody. Similar to our
observations with EM, the Galnt11 MO injected side appeared to have an increased ciliaclump density compared to the uninjected side. Conversely, injection of GALNT11 RNA on
one side significantly decreased the cilia-clump density compared to control (Fig. 12).

Figure 13. Immunofluorescence pictures illustrating that Galnt11 and Notch affect the
epidermal cilia clump density in a similar manner. On the left, knockdown of either
Galnt11 or Notch1 produces an increase in cilia clump density, while on the right,
overexpression of either Galnt11 or Notch1 results in a decrease in cilia clump density.
Acetylated tubulin marks cilia in red, and GFP in green marks the embryo side that was
injected.
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There is an extensive literature that epidermal cilia density is regulated by Notch
signaling. Indeed, similar to our Galnt11 results, cilia-clump density increased when we
injected Notch1 MO, and decreased when we injected Notch ICD, which constitutively
activates the Notch pathway. These results suggest that Galnt11 and Notch either interact or
act in parallel pathways to affect cilia-clump density.

IV.8. Galnt11 affects cilia driven embryo gliding

Figure 14. Composite images of tadpole epidermal cilia gliding videos. Tadpole gliding
over a fixed time period can be seen as a white line. Overexpression with GALNT11 RNA
retards ciliary gliding, while knockdown with Galnt11 MO significantly speeds it up.
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Given that Galnt11 affects cilia-clump density, we wondered whether manipulation of
Galnt11 levels and cilia-clump density has any functional significance. To evaluate this, we
used a tadpole-gliding assay originally devised by Vick et al., which evaluates the ability of
epidermal cilia to propel an otherwise paralyzed tadpole across an agarose coated petri dish.
Again, embryos were injected at the two-cell stage in identical fashion as when evaluating
cilia density. When injected with Galnt11 MO, the tadpoles glided significantly faster on the
injected side compared to the uninjected side suggesting that at the very least the function of
these cilia are normal. Conversely, when injected with GALNT11 RNA, the tadpoles glided
significantly slower on the injected side compared to the uninjected side (Fig. 13). To be
clear, glide speed seemed to relate inversely with the dose of Galnt11; higher doses of
Galnt11 led to slower glide speeds which appeared to correlate nicely with cilia clump
density. Thus, different levels of Galnt11 do not appear to affect the function of individual
cilia, but do affect the ability of cilia clumps to collectively push fluid near the epidermis or
propel the tadpole on a hard surface based on the number of cilia clumps present.

IV.9. Galnt11 and Notch1 affect Coco and PitX2 expression and heart looping in a similar
manner
The epidermal results suggest that Galnt11 and Notch act in a similar manner. We
examined this possibility further by comparing the effect of each gene on the LR
developmental cascade, namely Coco and PitX2 expression, as well as heart looping. MO
knockdown of both Galnt11 and Notch1 yielded similar rates of heart looping defects that
were significantly higher than uninjected controls (Fig. 14). UC embryos had 2.9% heart
looping defects (1.1% A-loops, 1.8% L-loops, n = 112), compared with Galnt11 morphants

48
which, had 28.0% heart looping defects (26.5% A-loops, 1.5% L-loops, n = 100) and Notch1
morphants, which had 23.5% heart looping defects (20.6% A-loops, 2.9% L-loops, n = 103).
Overexpression with GALNT11 RNA yielded 34.1% heart looping defects (17.6% A-loops,
16.5% L-loops, n = 104), and NotchICD RNA 28.0% heart looping defects (26.0% A-loops,
2.0% L-loops, n = 116), , indicating that the overall rate of heart looping defects is similar,
but the proportion of A-loops vs. L-loops is different. GALNT11 overexpressed embryos had
an almost equal number of A-loops and L-loops, while Notch ICD overexpressed embryos
had mostly A-loops.

60%

Coco expression:
L=R
Absent
L>R

PitX2 expression:
Absent
Bilateral
Right

Heart Looping:
A - loop
L - loop

50%

40%

30%

20%

10%

0%

UC Galnt11 Notch
MO
MO

Galnt11 NICD
RNA RNA

UC Galnt11 Notch
MO
MO

Galnt11 NICD
RNA RNA

UC Galnt11 Notch
MO
MO

Galnt11 NICD
RNA RNA

Figure 15. Galnt11 and Notch affect heart looping, as well as Coco and PitX2 expression
in a similar manner.
PitX2 expression at the LPM was also similarly affected by knockdown of Galnt11
and Notch1. Compared to UC embryos which had 4.45% abnormal PitX2 expression (0%
right, 2.2% absent, 2.2% bilateral, n = 59), knockdown with Galnt11 MO yielded abnormal
PitX2 expression in 22.2% of embryos (0% right, 14.8% absent, 7.4% bilateral, n = 50),
while knockdown with Notch1 MO yielded abnormal PitX2 expression in 28% of embryos
(0% right, 24.0% absent, 2.0% bilateral, n = 65). Overexpression with GALNT11 RNA and
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NotchICD RNA yielded abnormal PitX2 expression in 29.4% (8.8% right, 2.9% absent,
17.6% bilateral, n =68) and 23.3% (0% right, 23.3% absent, 0% bilateral, n = 72) of
embryos, respectively. The PitX2 expression patterns at the LPM parallel the heart looping
patterns. Knockdown of either Galnt11 or Notch1 produces indistinguishable results with
similar rates of right, absent and bilateral expression. However, while overexpression with
GALNT11 and NICD RNA resulted in similar overall rates of abnormal PitX2 expression,
the relative ratios of right, absent and bilateral expression differed. GALNT11
overexpression resulted in mostly bilateral PitX2 expression defects, with smaller numbers of
absent and right expression. Notch ICD overexpression on the other hand only resulted in
absent PitX2 expression.
Coco expression at the GRP was similarly affected both by knockdown and
overexpression of Galnt11 and Notch. UC GRPs had 4.8% abnormal Coco expression (4.8%
R = L, 0% L > R, 0% absent, n = 35), compared with 21.8% abnormal Coco expression
(21.8% R = L, 0% L > R, 0% absent, n = 43) for Galnt11 MO injected GRPs, 27.6%
abnormal Coco expression (24.1% R = L, 3.4% L > R, 0% absent, n = 45) for Notch1 MO
injected GRPs, 39.4% abnormal Coco expression (21.7% R = L, 13% L > R, 4.3% absent, n
= 50) for GALNT11 RNA injected GRPs, AND 50.0% abnormal Coco expression (18.2% R
= L, 27.3% L > R, 4.6% absent, n = 41) for NICD RNA injected GRPs. This suggests that
both Galnt11 and Notch affect LR development upstream of Coco expression at the level of
the ciliated GRP. Interestingly, there was no divergence in Coco expression phenotype with
overexpression of Galnt11 and Notch as was seen with PitX2 expression and heart looping.

IV.10. Galnt11 MO can be rescued with Notch ICD and Su(H)-Ank, but not Delta
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Components of the Notch pathway, including Notch ligands and receptors are targets
for glycosylation. While glycosylation of Notch ligands has an unknown role, glycosylation
of Notch receptors acts to modify their sensitivity to ligand. Since Galnt11 is a
galactosyltransferase with no known target protein to date, we hypothesized that Galnt11
glycosylates Notch receptor to modify Notch signaling. To test whether Galnt11 affects the
function of Notch receptor we carried out a series of epistasis experiments.
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Figure 16. Abnormal PitX2 expression at the LPM in Galnt11 morphants can be rescued
with NotchICD and Su(H)-Ank, but not Delta.
We injected one-cell embryos with Galnt11 MO and evaluated for PitX2 expression
at the LPM. We then tried to rescue the abnormal PitX2 expression patterns induced by
Galnt11 MO by injecting RNA constructs for one of three basic Notch components in one of
two cells at the two-cell stage: Delta, Notch ICD, or Su(H)-Ank (Fig. 15). Positive control
embryos that were only injected with Galnt11 MO had 18.0% abnormal PitX2 expression
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(3.8% right, 10.3% absent, 4.0% bilateral, n = 76). When Galnt11 MO rescue was attempted
with Delta RNA there was 16.9% abnormal PitX2 expression (7.7% right, 4.6% absent, 4.8%
bilateral, n = 72). When Galnt11 MO rescue was attempted with Notch ICD RNA there was
7.0% abnormal PitX2 expression (1.2% right, 5.8% absent, 0% bilateral, n = 69). When
Galnt11 MO rescue was attempted with Su(H)-Ank RNA there was 3.2% abnormal PitX2
expression (1.6% right, 0% absent, 1.6% bilateral, n = 50). This suggests that knockdown of
Galnt11 can be rescued with Notch ICD and Su(H)-Ank, both downstream factors of Notch
receptor, but cannot be rescued with Delta ligand. The implications from these data are
twofold: 1) Since the Galnt11 MO phenotype cannot be rescued by Delta ligand, Galnt11 and
Notch are part of the same pathway, and not two separate parallel pathways, and 2) Galnt11
appears to be acting at the level of Notch receptor.

IV.11. Galnt11 MO phenotype can be rescued with Notch ICD on the left side
Given that for normal LR development Galnt11 is required on the left, but not right
side, we hypothesized that Notch ICD would preferentially rescue the Galnt11 MO
phenotype when injected on the left side. To test this we injected Galnt11 MO at the one-cell
stage and then co-injected Notch ICD RNA together with Alexa Fluor 488 fluorescent tracer
in one of two cells at the two-cell stage. The embryos were sorted based on whether Notch
ICD was injected on the left or right, and they were then evaluated for abnormal PitX2
expression at the LPM. Embryos that were injected with Notch ICD RNA on the right side
had 44.4% abnormal PitX2 expression (7.4% right, 3.7% absent, 33.3% bilateral, n = 67),
compared to those injected with Notch ICD RNA on the left side, which had 16.7% abnormal
PitX2 expression (0% right, 0% absent, 16.7% bilateral, n = 78) (Fig. 16). UC embryos had
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9.1% abnormal PitX2 expression (1.6% right, 0% absent, 1.6% bilateral, n = 57). This data
shows that when Galnt11 is knocked down, Notch signaling only needs to be upregulated on
the left side downstream of Notch receptor. Since Galnt11 appears to only be necessary on
the left side for proper heart looping, this further strengthens the argument that Galnt11 and
Notch are part of the same pathway.
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Figure 17. Abnormal PitX2 expression at the LPM in Galnt11 morphants can be rescued
only when NotchICD is injected on the left, but not the right side.
IV.12. The conserved glycosylation enzymatic domain of Galnt11 is required for proper
function
Galactosyltransferases contain a conserved DSH domain that is essential for their
enzymatic function. To further test the hypothesis that Galnt11 glycosylates Notch receptor,
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we identified a putative DSH enzymatic domain in Galnt11 and introduced a conservative
point mutation from histidine to alanine at amino acid 247. This substitution is predicted to
not affect the tertiary structure of Galnt11, and allowed us to test whether the enzymatic
galactosyltransferase function of Galnt11 is required for its role in LR development.
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Figure 18. A conservative point mutation in the catalytic glycosylating domain of
GALNT11 results in no abnormal heart looping or PitX2 expression.
We injected one-cell embryos with either wild type (WT) GALNT11 RNA or
mutated H247A GALNT11 RNA, and evaluated their PitX2 expression at the LPM, as well
as their heart looping. Consistent with our previous results, UC embryos had 4.4% abnormal
PitX2 expression (0% right, 2.2% absent, 2.2% bilateral, n = 57) and 2.9% abnormal heart
looping (1.1% A-loops, 1.8% L-loops, n = 145), while embryos injected with WT GALNT11
RNA had 29.4% abnormal PitX2 expression (8.8% right, 2.9% absent, 17.6% bilateral, n =
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53) and 34.1% abnormal heart looping (17.6% A-loops, 16.5% L-loops, n = 58). However,
embryos injected with mutated H247A GALNT11 RNA had 2.5% abnormal PitX2
expression (0% right, 2.5% absent, 0% bilateral, n = 137) and 5.3% abnormal heart looping
(2.3% A-loops, 3.0% L-loops, n = 124), indicating that the DSH catalytic domain of Galnt11
is required to affect asymmetric LR development and further strengthening the argument that
Galnt11 and Notch not only act in the same pathways, but that Galnt11 glycosylates Notch.

IV.13. Galnt11 knockdown and overexpression results in abnormal LRO cilia morphology
Notch is instrumental in cell-fate specification in many tissues, including the Xenopus
epidermis where it specifies between ciliated and non-ciliated epidermal cells under the
influence of Galnt11. Given that Galnt11 protein is strongly localized at the LRO in crown
cells directly surrounding pit cells, we investigated any evidence of cell fate specification
changes in the LRO of Xenopus embryos injected with Galnt11 MO. Indeed, the maximal
LRO width in Galnt11 morphants was significantly less than that of control embryos (UC =
181.9 ± 21.4µm vs. Galnt11 MO = 142.1 ± 29.9µm, p < 0.0001), suggesting that Galnt11
controls specification between crown cells and pit cells at the LRO.

IV.14. Galnt11 affects FoxJ1, and RFX2 expression at the LRO
Mouse evidence suggests that there are two sets of primary cilia at the LRO, motile
and sensory, with motile cilia primarily located in the pit cells and sensory cilia primarily
located in the surrounding crown cells. Our evidence indicates that manipulation of Galnt11
leads to changes in LRO width. To see if these changes in LRO morphology result in
changes in cell fate specification, we looked at expression patterns of the motile ciliary genes
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FoxJ1 and RFX2 (Fig. 19). In situ hybridization revealed that compared to UC, both FoxJ1
and RFX2 had significantly decreased expression at the LRO in embryos injected with
GALNT11 RNA, while Galnt11 morphants had significantly stronger expression patterns of
both genes. Given that immunohistochemistry of the LRO in both overexpressors and
morphants of Galnt11 shows that cilia are present, these results indicate that the fates of these
cilia changes with changing levels of Galnt11. When overexpressed, motile cilia are
suppressed, and when knocked down, motile cilia are upregulated.

Figure 18. In situ hybridization pictures illustrating that Galnt11 affects ciliary motility
genes FoxJ1 and RFX2. With overexpression of Galnt11, both FoxJ1 and RFX2
expression nearly disappears, while knockdown of Galnt11 results in much stronger
expression of both genes. Gene expression is in blue, while RedGal injection tracer is in
red.
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V. DISCUSSION
Galnt11 is a previously uncharacterized putative glycosylating agent that was
identified through a CNV analysis of patients with heterotaxy. We have shown that Galnt11
is a galactosyltransferase that glycosylates Notch to regulate the development of the LR axis
by specifying between motile and sensory ciliary cell fates at the LRO.

V.1. Galnt11, Notch and LR patterning
There is extensive evidence that Notch signaling is regulated by glycosylation. Pofut1
is a permissive factor that is required for Notch signaling,83,84 while Fringe is a modifying
factor that can potentiate or attenuate Notch signaling based on the specific ligand/receptor
interaction.98-100 Our data establishes that Galnt11 modifies Notch signaling, but it is unclear
whether Galnt11 glycosylation is absolutely necessary for Notch signaling. However,
because both knockdown and overexpression of Galnt11 results in LR axis defects, it appears
that Galnt11 is an instructive and not a permissive factor. To our knowledge, Galnt11 is the
first enzyme identified to modify Notch with an N-galactose sugar. We pinpointed the action
of Galnt11 at the level of Notch receptor through a series of epistasis experiments which
showed that the Galnt11 morphant phenotype can be rescued with NotchICD and Su(H)-Ank,
both downstream factors of Notch receptor, but not Delta, which is an upstream ligand.
Additionally, the lack of phenotype following a conservative mutation of the catalytic
domain of Galnt11 indicates that the glycosylating function of Galnt11 is necessary for
interaction between the two proteins. Finally, unlike Fringe glycosylation, which only affects
Notch inductive signaling, Galnt11 glycosylation appears to also affect lateral inhibition, as
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demonstrated by the varying epidermal cilia clump density. To our knowledge Galnt11 is the
first non-permissive Notch glycosylation factor to do so.
Previous work implicates Notch signaling at several steps in the LR developmental
cascade. Notch is required for peri-LRO expression of Nodal,112,116 and suppression of Notch
signaling is necessary for PitX2 expression at the LPM.121,152 Data that Notch signaling may
be required for Nodal expression at the left LPM,116,122 may influence LRO ciliary length,115
and may induce asymmetry through asymmetric Dll1 expression at the LRO is more
controversial.116 Here we show that in addition to regulating the expression of Nodal and
PitX2, Notch is also involved in the specification of motile and sensory cilia at the LRO.
There are several lines of evidence to support this conclusion. Mouse work indicates
that mutants that lack motor ciliary components (e.g. dynein motor proteins) develop
predominantly either situs solitus or situs inversus,30,153 while mutants that lack proteins that
are required for the formation of cilia in general (e.g. intraflagellar transport proteins) also
develop heterotaxy in significant numbers.13,33,154,155 While not yet demonstrated directly, this
difference is presumably because in the case of motor cilia mutants flow is impaired but
sensation is intact, and solitus develops based on random fluid perturbations that direct the
LR axis towards either SS or SI. It may seem improbable that such small fluid currents would
be able to induce the LR cascade, but recent evidence suggests that LRO sensory cilia are
sensitive to flow created by as few as two cilia.156 On the other hand, when all cilia are
impaired, no sensory signal of any kind can be transmitted, thus resulting in lack of
asymmetric specification and subsequent formation of heterotaxy.
Interestingly, our data shows that manipulations of Galnt11 can produce both
phenotypes. Knockdown produces approximately the same proportion of A- and L-loops,
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while overexpression yields almost exclusively L-loops. Mouse data suggests that such
phenotypes are consistent with manipulations of motile or sensory cilia at the LRO, and
indeed that is what we have found. The alterations in LRO morphology and almost complete
absence of motile cilia markers FoxJ1, RFX2 and DNAH11 in the presence of normal
appearing LRO cilia with overexpression of Galnt11 indicates that there is a decreased
number of motile cilia. The alternative case with knockdown of Galnt11 is more difficult to
deduce. Even though the presence of both A-loops and L-loops combined with alterations in
LRO morphology and changes in FoxJ1, RFX2 and DNAH11 suggests a decrease in sensory
cilia, to the best of our knowledge there are currently no exclusively sensory cilia markers.
Pkd2 has been shown to be involved in the sensation of LRO flow in the mouse, but
immunohistochemistry revealed that the channel is present in all LRO cilia, both motile and
sensory. Loss of sensory cilia can most directly be demonstrated with a combination of LRO
flow analysis and Coco expression patterns at the LRO. Since Coco, the first gene to become
asymmetrically expressed in direct response to LRO flow, has abnormal expression patterns
in Galnt11/Notch1 morphants, a demonstration of normal flow would indicate absence of
sensory function in the LRO cilia. While we did not perform LRO flow analyses, our
epidermal tadpole glide assays show normal epidermal ciliary function in Galnt11, indirectly
suggesting normal LRO flow function. Epidermal ciliary function has previously been shown
to correlate with LRO ciliary flow, suggesting that even though Galnt11 morphants have
appropriate flow, they develop abnormal Coco expression patterns (and consequently
abnormal LR axis) because of lack of sensory LRO cilia.
Inhibition of Notch signaling by BCL6 and BCoR has recently been shown to be
necessary for proper PitX2 expression at the LPM.121 This effect appears to be independent
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of Nodal signaling at the LPM, which is generally thought to be required for PitX2
expression. Our in situ data supports these results. Coco expression patterns are
indistinguishable between manipulations of Galnt11 and Notch. However, the PitX2
expression patterns at the LPM diverge, such that overexpression with GALNT11 RNA
results in a significant amount of bilateral PitX2 expression, while overexpression with Notch
ICD RNA results in uniformly absent PitX2 expression. This indicates that even though
Notch signaling is involved in the regulation of the LR developmental cascade at multiple
steps, Galnt11 only regulates Notch signaling and influences LR development at the level of
the ciliated LRO. This is further supported by our in situ and immunohistochemistry data
which shows that Galnt11 is present in the LRO, and later in the tadpole kidneys, but not in
the LPM.

V.2. Galnt11 and the genetics of heterotaxy
Recent advances in genetic analysis, including quantitative interrogation of dense sets
of SNPs to identify small CNVs, whole exome sequencing, and as of late whole genome
sequencing, have given us the opportunity to investigate the genetic contribution of a variety
of complex disease processes. Using such approaches, studies have identified a myriad of
potential disease causing genes for conditions as diverse as heterotaxy,133 congenital
diaphragmatic hernias,157 and hypertension.158 However, determination of functional
significance, if any, of these potential gene candidates is severely complicated by the high
degree of locus heterogeneity, tremendous phenotypic variability and incomplete penetrance
of the diseases in question.
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With our work we clearly demonstrate that model organisms such as X. tropicalis
provide a powerful tool for functional validation of sequence variants. Previous work in the
lab identified 38 small CNVs encompassing 61 potential disease-causing genes.133 X.
tropicalis retains substantial synteny to human, and 38 of these identified genes have X.
tropicalis orthologs (unpublished data). This number is likely to increase, as the X. tropicalis
genome becomes better assembled. The previous assembly of the genome, for example,
yielded only 22 ortholog genes. 7 of those genes were deemed as highly likely to be disease
causing, based on expression patterns in the heart or ciliated organs such as the LRO or
kidneys. Knockdown of 5 of the 7 genes resulted in heart looping abnormalities, indicating a
significant level of functional significance. However, MO knockdown can result in nonspecific phenotypes. By delineating in detail the mechanism of action of one of those genes,
namely Galnt11, we have definitively demonstrated its functional significance in the
pathogenesis of heterotaxy.
Generalizing from my work, we our one of the first to demonstrate that novel
activities and mechanisms can be a productive of human genetics especially for
developmental biology. Traditionally, model organisms have been used to understand
developmental processes such as LR patterning and inform us about human development and
disease. That approach has been only moderately successful. For example, all of the genes
that are currently implicated in LR patterning through the study of mice, chick, rabbit, frog
and zebrafish, account for only 10-20% of genetic malformations in patients with
heterotaxy.127,128 Instead, we would argue that aggressive analysis of the genetic variations in
patients with congenital malformations such as Htx may be an extraordinary alternative to
model system discovery especially since we can directly then address human disease. This
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will require forging new alliances between high-throughput model organisms embryologists,
clinicians, and human geneticists. The challenges for the human geneticists for studying
congenital malformations is not trivial. The genetics of congenital malformations are fraught
with locus heterogeneity, complex and variable phenotypes, and relative rarity without
extensive pedigrees due to severely reduced fitness that make it very difficult to prove
disease causality on the basis of genetic analysis alone. However, the extraordinary power of
genome sequencing has simply changed the game making even these complex genetic
phenotypes tractable. Also, we anticipate that much of the disease burden is likely to be
genetic as opposed to environmental, and the disease is severe so that mutations are not likely
to be carried within the populations (ie rare or de novo) which can be used as a powerful
filtering method amongst the many variations found in human genomes. Our results would
suggest that the genetics can be analyzed and be highly fruitful. Finally, my results would
suggest that even rare patients may lead to extraordinary discoveries into the nature of our
embryonic development that is critical for our understanding of human disease.
On the other hand, the process of LR patterning also influences how we view human
heterotaxy. So far, any malformation of the LR axis in between SS and SI has been simply
classified as heterotaxy. The disease specifics are then specified through a description of the
macroscopic manifestations, such as left atrial isomerism or isolated dextrocardia with
abdominal situs solitus. Our work suggests that heterotaxy is not a single disease process, but
rather a group of diseases that all affect LR patterning. With that in mind, we believe that
heterotaxy should be redefined based on the genetic abnormality in question, such as cilia
motility disorders, cilia sensation disorders, TGF-beta disorders, etc. Data that Down’s
syndrome patients with AV canal malformations have significantly better short- and
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medium-term outcomes compared to non-Down’s syndrome patients with AV canal159
suggests that the specific genetic background of the disease can produce varying outcomes
for what appear to be a macroscopically identical disease processes. Classifying heterotaxy
patients as suggested may produce similar results and lead to better understanding of
prognosis and management. For example, a heterotaxy patient with a sensory cilia
malformation is much more likely to have kidney dysfunction than a heterotaxy patient with
a TGF-beta mutation affecting Nodal signaling.
Clinically, this has a number of implications. First and foremost, our analysis can
provide needed information to families with children that suffer from congenital
malformations who often simply want answers. For the first time, we may be able to provide
some. Second, by assigning disease causality, we can determine if the mutation is de novo,
recessive, or inpenetrant in parents, which will provide critical genetic counseling
information. Finally, clearly we are simply scratching the surface of the genes that affect
embryonic development. Improving our understanding will surely lead to better
prognostication, tailored therapies per genetic lesion, and new drug targets.
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